Cell analysis for hematopoietic stem/progenitor cell transplantation

被引:0
作者
Law, P
Traylor, L
Recktenwald, DJ
机构
[1] BD Biosci, San Jose, CA 95131 USA
[2] Univ Calif San Diego, Blood & Marrow Transplantat Program, La Jolla, CA USA
[3] AmCell Corp, Sunnyvale, CA USA
来源
CYTOMETRY | 1999年 / 38卷 / 02期
关键词
progenitor/stem cell subsets; cytometry; transplantation;
D O I
10.1002/(SICI)1097-0320(19990415)38:2<47::AID-CYTO1>3.0.CO;2-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cytometric analysis has become an important aspect in the quality control of cells in all phases of hematopoietic cell transplantation. In the stage of donor conditioning the counting of stem and progenitor cells is important and several reliable single platform tests for CD34+ cells have become available recently. It has been shown, that the count of certain subsets of CD34 may predict best time for harvesting stem cells better than just CD34. In many cases manipulation of the cell sample after collection from the donor is necessary before the cells are adequate for transplantation. Characterization of the resulting cell preparations requires reliable quantitative analysis of a variety of cell types like the enumeration of T-cells at the level of one in ten thousand for some allogeneic transplantations. It is discussed how these clinical requirements will need a refinement of cytometric procedures to achieve adequate clinical decisions. Cytometry (Comm. Clin. Cytometry) 38: 47-52, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 78 条
[1]  
Agrawal YP, 1996, EXP HEMATOL, V24, P738
[2]  
AMOS TAS, 1995, CELL TRANSPLANT, V4, P547
[3]  
Anderlini P, 1997, BLOOD, V90, P903
[4]  
[Anonymous], 1993, Clinical Flow Cytometry: Principles and Applications
[5]   Immune reconstitution following transplantation of selected hematopoietic stem cells [J].
Archimbaud, E .
HEMATOLOGY AND CELL THERAPY, 1997, 39 (05) :264-268
[6]  
BENDER JG, 1994, BONE MARROW TRANSPL, V13, P479
[7]   A newly discovered class of human hematopoietic cells with SCID-repopulating activity [J].
Bhatia, M ;
Bonnet, D ;
Murdoch, B ;
Gan, OI ;
Dick, JE .
NATURE MEDICINE, 1998, 4 (09) :1038-1045
[8]  
Brecher M E, 1996, J Hematother, V5, P227, DOI 10.1089/scd.1.1996.5.227
[9]   Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies [J].
Brown, RA ;
Adkins, D ;
Goodnough, LT ;
Haug, JS ;
Todd, G ;
Wehde, M ;
Hendricks, D ;
Ehlenbeck, C ;
Laub, L ;
DiPersio, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (09) :3067-3074
[10]   RETRACTED: RECONSTITUTION OF HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY BY AUTOLOGOUS PROGENITOR CELLS GENERATED EX-VIVO (RETRACTED ARTICLE. SEE VOL 345, PG 64, 2001) [J].
BRUGGER, W ;
HEIMFELD, S ;
BERENSON, RJ ;
MERTELSANN, R ;
KANZ, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :283-287